UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

_________________ 

FORM 8-K  

CURRENT REPORT 

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934  

Date of Report (Date of earliest event reported): January 24, 2017 

THE CLOROX COMPANY

(Exact name of registrant as specified in its charter) 

_________________ [DATA_TABLE_REMOVED]

1221 Broadway, Oakland, California 94612-1888 

(Address of principal executive offices) (Zip code)  

(510) 271-7000 

(Registrant's telephone number, including area code)  

Not applicable 

(Former name or former address, if changed since last report)  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:  

[ ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)  

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

 Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 24, 2017, the Board of Directors (the “Board”) of The Clorox Company (the “Company”) elected Russell Weiner to the Board, effective February 6, 2017. The committees of the Board on which Mr. Weiner will serve have not yet been determined. Mr. Weiner will be provided with the Company’s standard non-employee director compensation and director indemnification agreement.  

A press release announcing the election of Mr. Weiner is filed as Exhibit 99.1 and is incorporated herein in its entirety.  

Item 9.01 Financial Statements and Exhibits 

 (d) Exhibits    

 Exhibit  Description 

 99.1  Press Release dated January 27, 2017, of The Clorox Company

SIGNATURES  

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.  

  THE CLOROX COMPANY 

 Date: January 27, 2017 By: /s/ Laura Stein   

  Executive Vice President – 

  General Counsel and Corporate Affairs

THE CLOROX COMPANY  

FORM 8-K  

INDEX TO EXHIBITS  

 Exhibit   Description   

 99.1  Press Release dated January 27, 2017, of The Clorox Company